HNN3.0

Project cooperationUpdated on 23 January 2026

Innovative Research Alliances for Next‑Generation Health Solutions

Internationalization & Resources Unit Head Manager at Centro de Investigaciones Biológicas Margarita Salas-CSIC

Madrid, Spain

About

CIB Margarita Salas (CSIC) offers multidisciplinary excellence across molecular biosciences, biomedicine and microbial‑plant biotechnology, providing high‑impact capabilities for Horizon Europe Cluster 1 Health collaborations. Our groups bring cutting‑edge expertise in infection biology, host–pathogen interactions, immunology, antimicrobial resistance (AMR), vaccine and antibody development, and advanced platforms relevant to pandemic preparedness. We contribute strong competencies in NAMs, organoids, advanced imaging, gene editing, multi‑omics, and computational approaches for disease modelling.

We also provide deep expertise in neurodegenerative disorders, mitochondrial dysfunction, rare diseases, cardiovascular biology, tumour progression, chemoresistance and metastasis, enabling innovative strategies in precision medicine, drug repurposing and target discovery. Our biotechnology programmes advance synthetic biology, microbial engineering, biosensing, biodegradation, and microbial systems relevant to biosecurity and health monitoring.

With highly complementary departments and state‑of‑the‑art technologies, the CIB is an exceptional partner for 2026–2027 Health WP topics, offering a robust translational ecosystem capable of accelerating breakthroughs in infectious disease control, AMR, advanced therapies, diagnostics, NAMs, personalised medicine, and high‑impact biomedical innovation.

Type

  • Partner seeks Consortium/Coordinator

Organisation

Similar opportunities

  • Project cooperation

    Connecting Disease Biology with Advanced Intervention and Next-Gen Health Solutions

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Ioanna Kalograiaki

    Internationalization Research Manager at Centro de Investigaciones Biológicas Margarita Salas-CSIC

    Madrid, Spain

  • Project cooperation

    Human Microbiome Analysis Platform for New Approach Methodologies (NAMs)

    • Consortium/Coordinator seeks Partners
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Simon Ringgaard

    Scientific Project Manager at mbiomics GmBH

    Munich, Germany

  • Project cooperation

    Collaboration: NAMs to advance biomedical research

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Sarka Lehtonen

    Research Director at A.I.Virtanen Institute for Molecular Sciences

    Kuopio, Finland